NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alvion Pharmaceuticals

Alvion Pharmaceuticals

Private
AthensHealthcare & Life Scienceshttps://alvionpharma.com/

Last Round

Strategic

Apr 1, 2026

Company Overview

Alvion Pharmaceuticals is a pharmaceutical company that develops and manufactures complex generic and value-added medicines for global markets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

generic pharmaceuticalsvalue-added medicinespharma licensingpharmaceutical out-licensingpharmaceutical supplyintellectual property licensingcontract developmentcomplex genericsregulatory affairsanalytical supportdrug developmentcontract development and manufacturing organizationCDMOnon-infringing formulationsIP powerhouse

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alvion Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Alvion Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alvion Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 1, 2026

Key People

Founding team and executive leadership

John Bouros

CEO

Executive Team

Alvion Pharmaceuticals Investors

Notable investors and investment history

Alvion Pharmaceuticals investors
InvestorRounds
iGrow Venture PartnersStrategic

Alvion Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alvion Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alvion Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersAthens
Employee Range22
Year Founded2013
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.